Absence of PMS2 Mutations in Colon-CFR Participants whose Colorectal Cancers Demonstrate Unexplained Loss of MLH1 Expression

Documenti analoghi

• Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants – have we been missing anything?
  di: Clendenning, Mark, et al.
  Pubblicazione: (2013)
• Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort
  di: Rosty, Christophe, et al.
  Pubblicazione: (2016)
• Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
  di: Dowty, JG, et al.
  Pubblicazione: (2012)
• Cancer risks for MLH1 and MSH2 mutation carriers
  di: Dowty, James G., et al.
  Pubblicazione: (2013)
• Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome
  di: Zighelboim, Israel, et al.
  Pubblicazione: (2009)